Skip to content

Alzheimer's Disease Health Center

Experimental Alzheimer's Drug Halted

Drug Flurizan Didn't Meet Maker's Goals in Latest Tests
Font Size
A
A
A
By
WebMD Health News
Reviewed by Louise Chang, MD

July 2, 2008 -- It's the end of the road for Flurizan, an experimental Alzheimer's disease drug, after disappointing results in its latest study.

Myriad Genetics, which was developing Flurizan, says it's discontinuing work on the drug.

In a preliminary study recently published in The Lancet, Flurizan looked like it might slow functional decline in Alzheimer's patients.

But in Flurizan's latest study -- an 18-month trial in patients with mild Alzheimer's disease -- Flurizan didn't meet the researchers' benchmark for its effects on cognition (mental skills) and daily activities.

Today on WebMD

Remember your finger
When it’s more than just forgetfulness.
senior man with serious expression
Which kinds are treatable?
 
senior man
Common symptoms to look for.
mri scan of human brain
Can drinking red wine reverse the disease?
 
senior man
ARTICLE
daughter and father
ARTICLE
 
Making Diagnosis
Article
Colored mri of brain
ARTICLE
 
Close up of elderly couple holding hands
VIDEO
senior woman with lost expression
ARTICLE
 
Woman comforting ailing mother
ARTICLE
Alzheimers Dementia
ARTICLE